HIMS Stock Declines Despite Launch of New Specialty in Women's HealthZacks Investment Research • 10/21/25
Hims & Hers: Q3 Could Provide Volatility, But The Long-Term Vision Remains BrightSeeking Alpha • 10/21/25
S&P 500, Nasdaq Slide On Bad Loan Fears; Broadcom, Hims, Oracle Are Top Stocks To WatchInvestors Business Daily • 10/16/25
Weight-loss drugs shook up the stock market. Menopause treatments could be next.Market Watch • 10/15/25
Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026Business Wire • 10/15/25
Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell?Zacks Investment Research • 10/14/25
Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025Business Wire • 10/13/25
Hims & Hers Expands Personalized Care Access Via Telehealth PlatformZacks Investment Research • 10/09/25
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor's OfficeBusiness Wire • 10/09/25
Hims & Hers Looks To Close $10 ARPU Gap With Product Expansion And PartnershipsSeeking Alpha • 10/08/25